PMC9885030_01
Renal pelvis cancer (FDG 6.5) on PET-CT.
10.1177_11795476221150597-fig1.jpg
PMC9885030_01_10.1177_11795476221150597-fig1.jpg
fig1-11795476221150597
Abdominal contrast-enhanced MRI and further tests detected the third primary cancer in the left renal pelvis (Figure 1).
Diagram of disease progression.
10.1177_11795476221150597-fig2.jpg
PMC9885030_01_10.1177_11795476221150597-fig2.jpg
fig2-11795476221150597
Figure 2 below is the timeline of her disease progression illustrating when her 4 primary cancers were detected.
Histopathological image of thyroid cancer.
10.1177_11795476221150597-fig3.jpg
PMC9885030_01_10.1177_11795476221150597-fig3.jpg
fig3-11795476221150597
The histopathological images of 4 sites were presented in the Figures 3 to 6.
Histopathological image of colon cancer.
10.1177_11795476221150597-fig4.jpg
PMC9885030_01_10.1177_11795476221150597-fig4.jpg
fig4-11795476221150597
The histopathological images of 4 sites were presented in the Figures 3 to 6.
Histopathological image of left renal pelvic cancer.
10.1177_11795476221150597-fig5.jpg
PMC9885030_01_10.1177_11795476221150597-fig5.jpg
fig5-11795476221150597
The histopathological images of 4 sites were presented in the Figures 3 to 6.
Histopathological image of bladder cancer.
10.1177_11795476221150597-fig6.jpg
PMC9885030_01_10.1177_11795476221150597-fig6.jpg
fig6-11795476221150597
The histopathological images of 4 sites were presented in the Figures 3 to 6.